| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |